We are using cookies in order to facilitate your navigation on this website. You can read about how we use cookies and how to manage them here. By continuing to navigate on this website or clicking on the button, you accept our cookie notice and related Privacy Policy. I accept the use of cookies Molecular Partners Home About Us DARPin Biology The DARPin Platform Pipeline Investors Partnering Careers Contact Us What is a DARPin® therapeutic? Our pipeline Our infectious disease program Latest news NOVEMBER 30 Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro NOVEMBER 24 Molecular Partners Announces Presentation at the Evercore ISI 4th Annual HealthCONx Conference SEE ALL >> What drives us We are deeply motivated to deliver unique therapies to people with cancer and other serious diseases. Hear what drives us to go the extra mile. Previous The Molecular Partners team is unique because we share a common vision and combine our diverse experiences and skill sets to achieve our goals. I’ve known this company from the beginning, and I still find that doing something that matters inspires me every day. Gaby Next COOKIE NOTICE PRIVACY & DISCLAIMER CONTACT US © 2021 Molecular Partners.